Healthcare -
Biotechnology - NASDAQ - US
$ 43.57
-12.4 %
$ 1.51 B
Market Cap
-10.75
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Disc Medicine, Inc.
| Net Income | -109 M |
| Depreciation & Amortization | 156 K |
| Capital Expenditures | -505 K |
| Stock-Based Compensation | 16.8 M |
| Change in Working Capital | 1.55 M |
| Others | 3.14 M |
| Free Cash Flow | -94.4 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (109.4) | (76.4) | (46.8) | (36.0) | (40.8) |
| Depreciation & Amortization | 0.2 | 100 K | 89 K | 32 K | 0.3 |
| Deferred Income Tax | 0 | 0 | 0 | 5.0 | 8 K |
| Stock Based Compensation | 16.8 | 5.5 | 2.09 K | 507 | 123 |
| Other Operating Activities | (3.1) | 0.3 | 0.3 | 1.6 | 6.5 |
| Change in Working Capital | 1.6 | (3.0) | 2.1 | 1.3 | 0.3 |
| Cash From Operations | (93.9) | (73.5) | (42.3) | (27.5) | (32.7) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.5) | 89 K | (0.2) | 68 K | 22 K |
| Other Items | (291.8) | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (292.3) | 89 K | (0.2) | 68 K | 22 K |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 29.0 | 0 | 0 | 0 | 14.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.0 | 40.3 | 95.5 | 89.9 | 20.2 |
| Cash From Financing Activities | 218.3 | 239.4 | 149.0 | 89.9 | 34.2 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (167.9) | 165.8 | 106.6 | 62.3 | 1.5 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (94.4) | (73.6) | (42.4) | (27.6) | (32.7) |